This research investigates the hypothesis that publicly funded scientific research complements private R&D investment in the pharmaceutical industry. New microlevel data on public research investment by the U.S. National Institutes of Health allow measures of basic and clinical research in seven...

In this paper we empirically test whether public R&D subsidies crowd out private R&D investment in Flanders and Germany, using firm level data from the Flemish and German part of the Community Innovation survey (CIS III and IV). Both the non-parametric matching estimator and the conditional...

Is public R&D spending complementary and thus "additional" to private R&D spending, or does it substitute for and tend to "crowd out" private R&D? Conflicting answers are given to this question. We survey the body of available economectric evidence accumulated over the past 35 years. A framework...

The purpose of this paper is to investigate the rivalry between basic and applied research within public research labs. Study design considers the international publications a proxy of basic research, whereas the self-financing deriving from technology transfer activities is an indicator of...

For decades, the US public and private sectors have committed substantial resources towards cancer research, but the societal payoff has not been well-understood. We quantify the value of recent gains in cancer survival, and analyze the distribution of value among various stakeholders. Between...

The purpose of this paper is to analyse the relationship between bureaucracy and research performance within Public Research Bodies. The research methodology is applied on a sample of 100 interviewed belonging to 11 institutes of National Research Council of Italy. The main finding is that...